Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
- PMID: 8147304
- DOI: 10.1016/0002-9149(94)90337-9
Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
Abstract
Although hypertrophic cardiomyopathy (HC) is believed to be a relatively uncommon cardiac disease, the frequency with which it occurs in the general or cardiac population has not been defined. To address this issue, the patient population of a community-based echocardiography laboratory was used to assess the prevalence of HC in 714 consecutively studied outpatients with (or suspected of having) heart disease. The most common cardiac disease identified was mitral valve prolapse (73 patients [10%]), and HC was present in 4 patients (0.5%). Ages were 50 to 69 years. Maximal left ventricular wall thicknessess were 15 to 22 mm (mean 19); only 1 had evidence of obstruction to left ventricular outflow by virtue of marked mitral valve systolic anterior motion. Before echocardiographic study, each of the 4 patients with HC had signs or symptoms of cardiac disease, but the correct diagnosis had not been suspected. Of 11 other patients who were referred for echocardiographic study because of a clinical suspicion of HC, none proved to have this disease. The present study demonstrates that HC is a particularly uncommon disease entity occurring in about 0.5% of an unselected outpatient population referred for echocardiographic study.
Similar articles
-
Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).Am J Cardiol. 2004 Jun 15;93(12):1510-4. doi: 10.1016/j.amjcard.2004.03.007. Am J Cardiol. 2004. PMID: 15194022
-
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.Circulation. 1995 Aug 15;92(4):785-9. doi: 10.1161/01.cir.92.4.785. Circulation. 1995. PMID: 7641357
-
Simultaneous occurrence of mitral valve prolapse and systolic anterior motion in hypertrophic cardiomyopathy.Am J Cardiol. 1991 Feb 15;67(5):404-10. doi: 10.1016/0002-9149(91)90050-u. Am J Cardiol. 1991. PMID: 1994665
-
Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights.J Am Soc Echocardiogr. 2016 Jul;29(7):622-39. doi: 10.1016/j.echo.2016.03.003. Epub 2016 Apr 14. J Am Soc Echocardiogr. 2016. PMID: 27146120 Review.
-
Echocardiography for hypertrophic cardiomyopathy.Prog Cardiovasc Dis. 2014 Jul-Aug;57(1):91-9. doi: 10.1016/j.pcad.2014.05.007. Epub 2014 May 20. Prog Cardiovasc Dis. 2014. PMID: 25081404 Review.
Cited by
-
Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information.Clin Res Cardiol. 2024 May;113(5):728-736. doi: 10.1007/s00392-023-02310-4. Epub 2023 Oct 4. Clin Res Cardiol. 2024. PMID: 37792019 Free PMC article.
-
ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy.Neth Heart J. 2007;15(6):216-20. doi: 10.1007/BF03085983. Neth Heart J. 2007. PMID: 17612686 Free PMC article.
-
Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.Mol Genet Genomic Med. 2019 Aug;7(8):e841. doi: 10.1002/mgg3.841. Epub 2019 Jul 10. Mol Genet Genomic Med. 2019. PMID: 31293105 Free PMC article.
-
Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review.Int J Mol Sci. 2021 Aug 29;22(17):9378. doi: 10.3390/ijms22179378. Int J Mol Sci. 2021. PMID: 34502285 Free PMC article. Review.
-
Sudden death in athletes.Clin Med (Lond). 2012 Jun;12(3):253-6. doi: 10.7861/clinmedicine.12-3-253. Clin Med (Lond). 2012. PMID: 22783778 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources